U.S. Markets close in 5 hrs 16 mins
  • S&P 500

    3,259.75
    +13.16 (+0.41%)
     
  • Nasdaq

    10,768.35
    +96.09 (+0.90%)
     
  • Russell 2000

    1,464.36
    +12.54 (+0.86%)
     
  • Crude Oil

    39.90
    -0.41 (-1.02%)
     
  • Gold

    1,864.60
    -12.30 (-0.66%)
     
  • Silver

    23.02
    -0.18 (-0.76%)
     
  • EUR/USD

    1.1636
    -0.0039 (-0.3374%)
     
  • 10-Yr Bond

    0.6540
    -0.0120 (-1.80%)
     
  • Vix

    28.50
    -0.01 (-0.04%)
     
  • GBP/USD

    1.2715
    -0.0037 (-0.2886%)
     
  • BTC-USD

    10,637.88
    -122.71 (-1.14%)
     
  • CMC Crypto 200

    226.15
    +8.32 (+3.82%)
     
  • FTSE 100

    5,827.12
    +4.34 (+0.07%)
     
  • Nikkei 225

    23,204.62
    +116.80 (+0.51%)
     

Meridian Bioscience: Fiscal 2Q Earnings Snapshot

CINCINNATI (AP) _ Meridian Bioscience Inc. (VIVO) on Tuesday reported fiscal second-quarter net income of $7.1 million.

On a per-share basis, the Cincinnati-based company said it had profit of 17 cents. Earnings, adjusted for costs related to mergers and acquisitions and non-recurring costs, were 19 cents per share.

The diagnostic test maker posted revenue of $50.2 million in the period.

Meridian Bioscience shares have dropped 23% since the beginning of the year. The stock has fallen 8% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VIVO at https://www.zacks.com/ap/VIVO